Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Jet Approach for Refractory Meibomian Gland Dysfunction Patients

NCT04608942 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT04608942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04608942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Jet Approach for Refractory Meibomian Gland Dysfunction Patients
Lead sponsor
Federal University of São Paulo
Phase
Not applicable
Overall status
Unknown status
Start date
November 11, 2019
Completion date
August 31, 2022
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, evaporative dry eye, inflammation, meibomian gland dysfunction, tear film deficiency